drugset / Trial / NCT02130674

Optimized Therapy in Severe Traumatic Brain Injured Patients

NCT02130674

NaSingle-groupOpen-labelTreatment

Summary

Severe traumatic brain injury is associated with life-threatening and incapacitating secondary injury. Contemporary therapeutic interventions are aimed at preventing and treating secondary damage. In this context, improved cerebral metabolism is an important target in modern neurointensive care. The main hypothesis is that continuous intravenous infusion of glutamyl-alanyl dipeptide restores disturbed brain metabolism following severe traumatic brain injury.

Timeline

Start
2005-01
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dipeptiven Peptide 0.75 g/kg Intravenous